Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more
Par Drugs And Chemicals Limited (PAR) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.146x
Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) has a cash flow conversion efficiency ratio of 0.146x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹115.00 Million) by net assets (₹785.98 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Par Drugs And Chemicals Limited - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Par Drugs And Chemicals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Par Drugs And Chemicals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Par Drugs And Chemicals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CREDICORP
BE:D8V
|
0.098x |
|
Palatin Technologies Inc
NYSE MKT:PTN
|
0.838x |
|
RENAISSANCERE HLDG
BE:RRJ
|
0.082x |
|
UCB - Dusseldorf Stock Exchang
DU:UNC
|
N/A |
|
Saigon General Service Corp
VN:SVC
|
N/A |
|
JATCORP LTD.
F:3J2
|
N/A |
|
TURA GROUP AB
F:8WO
|
N/A |
|
CARLO GAVAZZI
BE:D9N
|
N/A |
Annual Cash Flow Conversion Efficiency for Par Drugs And Chemicals Limited (2016–2025)
The table below shows the annual cash flow conversion efficiency of Par Drugs And Chemicals Limited from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹989.75 Million | ₹161.60 Million | 0.163x | -30.95% |
| 2024-03-31 | ₹856.32 Million | ₹202.49 Million | 0.236x | +25.93% |
| 2023-03-31 | ₹712.38 Million | ₹133.77 Million | 0.188x | +47.65% |
| 2022-03-31 | ₹598.77 Million | ₹76.15 Million | 0.127x | -45.05% |
| 2021-03-31 | ₹522.15 Million | ₹120.85 Million | 0.231x | +22.22% |
| 2020-03-31 | ₹406.15 Million | ₹76.91 Million | 0.189x | -27.23% |
| 2019-03-31 | ₹291.17 Million | ₹75.77 Million | 0.260x | +24.73% |
| 2018-03-31 | ₹206.99 Million | ₹43.18 Million | 0.209x | -56.32% |
| 2017-03-31 | ₹192.03 Million | ₹91.72 Million | 0.478x | +27.00% |
| 2016-03-31 | ₹173.56 Million | ₹65.27 Million | 0.376x | -- |